ScholarWorks@SOONCHUNHYANG UNIVERSITY: Kim, Young Seok

Detailed Information

Kim, Young Seok (김영석)

College of Medicine (Department of Internal Medicine)

Research Area

Tel
E-mail
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Hepatocellular carcinoma:15||hepatocellular carcinoma:13||Liver cirrhosis:9||hepatocellular:8||Carcinoma:8||Hepatitis C:7||Korea:7||Hepatitis B virus:6||transient elastography:5||hepatitis C virus:5||Prognosis:5||Epidemiology:5||Sorafenib:5||Ribavirin:5||Cirrhosis:5||Hepatic arterial infusion chemotherapy:4||chronic:4||liver cirrhosis:4||Hepatitis C virus:4||hepatitis B:4||chronic hepatitis B:4||liver stiffness:4||Chronic hepatitis C:4||Chronic hepatitis B:3||Treatment:3||epidemiology:3||fatty liver:3||Mortality:3||antiviral therapy:3||Diagnosis:3||risk prediction:3||mortality:3||Hepatitis B:3||의약학:3||Gastric varices:3||Transient elastography:3||Case report:2||Depression:2||Alcohol:2||Variceal hemorrhage:2||소화기내과:2||소화기내과학:2||hepatitis B virus:2||hepatorenal syndrome:2||5Fluorouracil:2||Peginterferon alfa:2||incidence:2||Virologic response:2||Chemoembolization:2||Glomerular Filtration Rate:2||jaundice:2||Liver injury:2||liver fibrosis:2||Elasticity imaging techniques:2||Cisplatin:2||Portal hypertension:2||HVPG:2||Portal vein tumor thrombosis:2||Alcoholic hepatitis:2||Sofosbuvir:2||ascites:2||autoimmune hepatitis:2||Metaanalysis:2||Biopsy:2||Hepacivirus:2||Prevalence:2||Survival:2||Sustained virologic response:2||cardiovascular disease:2||chronic liver disease:2||cirrhosis:2||Tenofovir:2||Autoimmune hepatitis:2||Tenofovir disoproxil fumarate:2||Hepatitis:2||Therapeutics:2||Hepatitis A:2||Entecavir:2||Nonalcoholic fatty liver disease:2||Recurrence:2||Esophageal and gastric varices:2||Esophageal varices:2||treatment:2||Ultrasonography:2||genotype:2||Fibroscan 630:1||Fibrosis:1||Fluorodeoxyglucose F18:1||Framingham risk score:1||Fundal varices:1||Gadolinium ethoxybenzyl DTPA:1||Gastric stromal tumor:1||Gastric variceal bleeding:1||Gastric varix:1||Gastrocaval shunt:1||Gastroesophageal varices:1||Gastrointestinal hemorrhage:1||Genotype:1||Genotype 1:1||Genotype 2:1||Genotype 6:1||HBV:1||HBV DNA:1||HBcrAg:1||HCV:1||HCV RNA:1||Hemoperitoneum:1||Hemorrhage:1||Hepatic venous pressure gradient:1||Hepatic venous pressure gradient (HVPG):1||Hepatitis B Virus:1||Hepatitis B core:1||Hepatitis C Virus:1||Hepatitis C virus (HCV):1||Hepatorenal syndrome:1||Hepatotoxicity:1||Herb:1||HiART system:1||High dose:1||Histoacryl (R) (Nbutyl2cyanoacrylate):1||Histoacryl (R) injection:1||Hospital Anxiety and Depression scale:1||Hypertension:1||Hypertension, Portal:1||Hypertension, portal:1||Immune checkpoint inhibitors:1||Immunohistochemistry:1||Immunotherapy:1||Impaction:1||Inflammation:1||Insulin resistance:1||Interferonα2b:1||Interferons:1||Interleukin28B:1||Intraductal ultrasonography:1||JX594:1||Jaundice:1||Journal Impact Factor:1||Keywords CRTC2:1||Klebsiella pneumoniae:1||Korean:1||Koreans:1||Lamivudine:1||Lamivudine resistance:1||Ledipasvir:1||Lipid metabolism:1||Lipid profile:1||Lipogenesis:1||Lipophagy:1||Liver Cirrhosis:1||Liver Damage:1||Liver cirrhosis, biliary:1||Liver disease:1||Liver fibrosis:1||Liver masses:1||Liver stiffness:1||Low dose:1||MAFLD:1||MELD:1||Magnetic resonance imaging:1||Metastasis:1||MicroRNA451:1||MicroRNAs:1||Morbidity:1||Muscle mass:1||Mutation:1||NacetylbetadGlucosaminidase:1||NAFLD:1||NCD:1||Neutrophiltolymphocyte ratio:1||Nonalcoholic fatty liver:1||Nonalcoholic fatty liver disease:1||Nonalcoholic steatohepatitis:1||Noninferiority trial:1||Nutrients:1||Occult infection:1||Oncolytic virus:1||Overestimation:1||Overlap syndrome:1||PARTO:1||PIVKAII:1||Pathology:1||Patients with liver cirrhosis and hepatocellular carcinoma (HCC) are often ineligible for resection or local ablation therapy due to poor liver:1||Peginterferon:1||Pegylated interferon alpha:1||Pegylated interferon alpha2b:1||Pentoxifylline:1||Pericardiacophrenic vein:1||Peritonitis:1||Plants, Medicinal:1||Plugassisted:1||Portal:1||Portal vein:1||Portasystemic shunt, surgical:1||Positronemission tomography:1||Predictor:1||Prescribed Medicines:1||Primary biliary cirrhosis:1||Prognostic Factor:1||Prognostic factors:1||Prophylaxis:1||Proteinuria:1||Pulmonary metastasis:1||Quality of life:1||ROC curve:1||Radiationinduced liver disease:1||Radiotherapy:1||Radixact:1||Real time shear wave elastography:1||Realtime elastography:1||Rebleeding:1||Recovery:1||Relation of Fibroblast Growth Factor Receptor 2 Expression to Hepatocellular Carcinoma Recurrence After Liver Resection:1||Relative adrenal insufficiency in chronic liver disease: itsprevalence and effects on longterm mortality:1||Renal Function:1||Republic of Korea:1||Rescue Therapy:1||Resistance:1||Restriction fragment mass polymorphism:1||Risk Assessment:1||Risk Factors:1||Risk factor:1||Risk factors:1||Risk of fatty liver after longterm use oftamoxifen in patients with breast cancer:1||Safety:1||Scoring system:1||Secondary prevention:1||SengstakenBlakemore tube:1||Serum Creatinine Level:1||Sex:1||Shear wave elastography:1||Side effect:1||Smoking:1||Social Media:1||Spleen stiffness:1||Spontaneous Bacterial Peritonitis:1||Spontaneous rupture:1||Stereotactic body radiation therapy:1||Surveillance:1||Sustained virological response:1||TRAIL Enhances Apoptosis of Human HepatocellularCarcinoma Cells Sensitized by Hepatitis C Virus Infection:Therapeutic Implications:1||TSC:1||Tenofovir alafenamide:1||Therapeutic:1||Thrombosis:1||Timing:1||Tomography:1||Toxic:1||Toxic hepatitis:1||Traditional Therapy:1||Transarterial chemoembolization:1||Transection:1||Transjugular intrahepatic portosystemic shunt:1||Transmission:1||Treatment of gastric varix:1||Treatment uptake:1||Trichrome stain:1||Tumor size:1||Upper gastrointestinal bleeding:1||Urinary bladder:1||Ursodeoxycholic acid:1||Variceal bleeding:1||Varices:1||Vascular endothelial growth factor:1||Vemlidy:1||Viral Hepatitis Outcome:1||Vitamin E:1||VogtKoyanagiHarada disease:1||Xray computed:1||acute cholestatic hepatitis:1||acute hepatitis:1||acute hepatitis A:1||acute kidney injury:1||adverse event:1||allocation:1||alternative treatment:1||antihepatitis C virus DAA:1||antibiotics:1||antisense drug resistance:1||antiviral agents:1||beta blocker:1||bevacizumab:1||biliary:1||bioelectrical impedance analysis:1||biopsy:1||cACLD:1||cancer of liver:1||chemoembolization:1||collagen:1||colon cancer:1||colonoscopy:1||comparison:1||complication:1||computerassisted:1||controlled attenuation parameter:1||core needle biopsy:1||creatinine:1||cystatin C:1||diabetes mellitus:1||diagnosis:1||diagnostic criteria:1||diagnostic value:1||dietinduced obesity:1||drug:1||druginduced liver injury:1||efficacy:1||empirical treatment:1||endoscopic ultrasoundguided fine needle aspiration:1||endoscopic variceal ligation:1||enhanced ultrasonography:1||extrahepatic:1||focal segmental glomerulosclerosis:1||health education:1||helical tomotherapy (HT):1||hepatic arterial infusion chemotherapy:1||hepatic encephalopathy:1||hepatitis A virus:1||hepatitis B e antigen:1||high cost:1||hyperlipidemia:1||image processing:1||infection:1||inflammation:1||intervention:1||intrahepatic cholangiocarcinoma:1||liver abscess:1||liver biopsy:1||liver transplant:1||liver transplantation:1||liverrelated mortality:1||lowMELD:1||mTORC1:1||mammalian target of rapamycin complex:1||medication:1||metaanalysis:1||miR34a:1||microbiome:1||morbidity:1||nonalcoholic fatty liver disease:1||noninferiority:1||normal chow diet:1||nutrition:1||nutrition education:1||overall survival:1||pazopanib:1||performance:1||polycystic liver disease:1||positron emission tomography:1||prevalence:1||prognosis:1||proteinuria:1||pyogenic liver abscess:1||radiofrequency ablation:1||renal cell carcinoma:1||renal dysfunction:1||renal function:1||renal insufficiency:1||risk factor:1||safety:1||seroconversion:1||shear wave elastography:1||smoking:1||sorafenib:1||spontaneous bacterial peritonitis:1||spontaneous portosystemic shunt:1||stereotactic body radiotherapy:1||stereotactic body radiotherapy (SBRT):1||subclinical ascites:1||survival:1||survival rate:1||tamoxifen:1||tenofovir:1||tenofovir disoproxil orotate:1||therapeutic:1||toxic hepatitis:1||transarterial chemoembolization:1||tuberous sclerosis complex:1||ultrasonography:1||upper gastrointestinal bleeding:1||variceal bleeding:1||varix:1||간 손상:1||간경변:1||독성간염:1||리비탈:1||바이러스반응:1||식도위정맥류:1||알라닌아미노전달효소:1||약제 내성:1||예후인자:1||우루사:1||위장관출혈:1||자가면역간염:1||조직병리학:1||진단:1||치료:1||테노포비어:1||16S rRNA nextgeneration sequencing:1||한국:1||25Hydroxyvitamin D deficiency:1||2DSWE:1||AFP:1||AFPL3:1||ASCITES:1||Abortion, induced:1||Acousticradiationforce impulse elastography:1||Acute hepatitis A:1||Acute hepatitis B:1||Acuteonchronic liver failure:1||Adefovir:1||Adipokines:1||Adiponectin:1||Alanine aminotransferase:1||Alcoholic cirrhosis:1||Angiomyolipoma:1||AntiHCV:1||Antiviral Resistance:1||Antiviral agents:1||Antiviral treatment:1||Anxiety:1||Ascites:1||Asian continental ancestry group:1||Autoimmune:1||Azathioprine:1||BRTO:1||Balloonoccluded retrograde transvenous obliteration:1||Baveno VI:1||Beck Depression InventoryI:1||Betablocker:1||Bibliometrics:1||Biphenyl dimethyl dicarboxylate:1||Bleeding:1||Blood platelets:1||B형간염:1||Cab39/MO25:1||Carcinoma, hepatocellular:1||CaseControl Studies:1||Casecontrol study:1||Chemotherapy:1||ChildPugh score:1||ChildTurcottePugh:1||Choledocholithiasis:1||Cholesterol:1||Chronic:1||Chronic Renal Insufficiency:1||Chronic hepatitis:1||Classification:1||Cohort study:1||Coinfection:1||Complete response:1||Computed tomography:1||Contrast:1||Contrast enhanced ultrasonography:1||Contrast media:1||Contrastenhanced ultrasonography:1||Corticosteroid:1||Criteria:1||Cyclooxygenase 2:1||Cyclooxygenase2:1||Cytokeratin18:1||Cytotoxic chemotherapy:1||DIO:1||Data systems:1||Drug:1||Drug resistance:1||Drug users:1||Druginduced Liver Injury:1||Druginduced liver injury:1||Elastography:1||Elbasvirgrazoprevir drug combination:1||Endoscopic retrograde cholangiopancreatography:1||Endoscopic scissors:1||Endoscopy:1||Endosonography:1||Ethanol:1||Etiology:1||Extrahepatic metastases:1||F18fluorodeoxyglucose:1||F18fluorodeoxyglucose positron emission tomography/computed tomography scan:1||Fatty liver:1||Feeding artery:1||Ferritin:1||Fibroscan:1||

RSS_1.0 RSS_2.0 ATOM_1.0

(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE